HALO
Halozyme Therapeutics, Inc. · Healthcare
President and CEO Helen Torley sold $1.3M of Halozyme Therapeutics, Inc.
Sold$1,292,750
$43.09Price
30,000Shares
−5%Stake
What HALO did after the filing
- The stock from Fri, Jul 28 open, $43.60
- −14.0%
- S&P 500, same days
- −1.6%
Measured over 30 trading days, to the Sep 11 close.
Traded Tue, Jul 25. Filed Thu, Jul 27, 4:03 PM ET, after the close. Returns use the Jul 28 open and the Sep 11 close. Not investment advice.